News from actavis, inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 21, 2014, 16:30 ET
Actavis plc logo. (PRNewsFoto/Actavis plc)

Medicines360 and Actavis Announce FDA Acceptance for Filing of NDA for Levosert™ IUD

Medicines360, a non-profit women's health pharmaceutical company, and Actavis plc (NYSE: ACT), a leading global specialty pharmaceutical company,...

Jul 11, 2014, 16:25 ET
Actavis plc logo. (PRNewsFoto/Actavis plc)

Actavis Confirms Generic Diclegis® Patent Challenge

 Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug...

Jul 08, 2014, 16:05 ET
Actavis plc logo. (PRNewsFoto/Actavis plc)

Actavis Confirms Generic Ampyra® Patent Challenge

 Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug...

Jul 02, 2014, 08:46 ET
Actavis plc logo. (PRNewsFoto/Actavis plc)

Actavis Completes Acquisition of Furiex Pharmaceuticals

Actavis plc (NYSE: ACT) today announced that its subsidiary Forest Laboratories, LLC has successfully completed its acquisition of Furiex...

Jul 02, 2014, 08:00 ET
http://photos.prnewswire.com/prnvar/20130124/NY47381LOGO

Actavis Announces Final Stockholder Merger Consideration Election Results in Connection with Forest Laboratories Acquisition

 Actavis plc (NYSE: ACT) today announced the final results of the elections made by stockholders of Forest Laboratories, Inc. ("Forest")...

Jul 01, 2014, 09:00 ET
Actavis plc logo. (PRNewsFoto/Actavis plc)

Actavis plc Appoints New Members and Announces Changes to Board of Directors Following Close of Forest Laboratories, Inc. Acquisition

Actavis plc (NYSE: ACT) today announced the appointment of three new members to the Company's Board of Directors, including Actavis' newly...

Jul 01, 2014, 08:30 ET
Actavis plc logo. (PRNewsFoto/Actavis plc)

Actavis Completes Forest Laboratories Acquisition

 Actavis plc (NYSE: ACT) today announced that it has completed the acquisition of Forest Laboratories, Inc. (NYSE: FRX) in a cash and equity...

Jul 01, 2014, 08:20 ET
Actavis plc logo. (PRNewsFoto/Actavis plc)

Actavis Completes Forest Laboratories Acquisition

 Actavis plc (NYSE: ACT) today announced that it has completed the acquisition of Forest Laboratories, Inc. (NYSE: FRX) in a cash and equity...

Jun 30, 2014, 17:15 ET
Actavis plc logo. (PRNewsFoto/Actavis plc)

Actavis and Forest Receive U.S. FTC Clearance for Actavis' Proposed Acquisition of Forest

 Actavis plc (NYSE: ACT) and Forest Laboratories, Inc. (NYSE: FRX) today announced that the U.S. Federal Trade Commission (FTC) has voted to...

Jun 30, 2014, 08:30 ET
Actavis plc logo. (PRNewsFoto/Actavis plc)

Actavis and Forest Announce Preliminary Stockholder Merger Consideration Election Results

 Actavis plc (NYSE: ACT) and Forest Laboratories, Inc. (NYSE: FRX) today announced the preliminary results of the elections made by...

Jun 30, 2014, 08:00 ET
Actavis plc logo. (PRNewsFoto/Actavis plc)

Actavis to Host Second Quarter 2014 Earnings Conference Call and Webcast

 Actavis plc (NYSE: ACT) today announced that it intends to release second quarter 2014 financial results on Tuesday, August 5, 2014, prior to...

Jun 30, 2014, 07:30 ET
Actavis plc logo. (PRNewsFoto/Actavis plc)

Actavis Confirms Generic Zubsolv® Patent Challenge

Actavis plc (NYSE: ACT) today confirmed that it has filed an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration...

Jun 26, 2014, 07:00 ET

Lowest Dose Oral Contraceptive for Preventing Pregnancy -- LOLO™ -- Now Available in Canada

OAKVILLE, ON, June 26, 2014 /CNW/ - As scientific evidence has accumulated, there has been a movement toward lower dose estrogen formulations of...

Jun 24, 2014, 08:30 ET
Actavis plc logo. (PRNewsFoto/Actavis plc)

Actavis and Forest Announce Tentative Election Deadline Of June 27, 2014

 Actavis plc (NYSE: ACT) and Forest Laboratories, Inc. (NYSE: FRX) today announced that the tentative election deadline  for Forest...

Jun 23, 2014, 08:30 ET
Actavis plc logo. (PRNewsFoto/Actavis plc)

Actavis and Forest Laboratories Announce Appointment of C. David Nicholson, PhD to lead Actavis Global Brands Research and Development

 Actavis plc (NYSE: ACT) and Forest Laboratories, Inc. (NYSE: FRX) today announced that C. David...

Jun 19, 2014, 08:30 ET
Actavis plc logo. (PRNewsFoto/Actavis plc)

Actavis Confirms District Court Ruling In Generic Exelon® Patch Patent Suit

 Actavis plc (NYSE: ACT) today confirmed that the United States District Court for the District of Delaware has found certain claims of United...

Jun 17, 2014, 16:05 ET
Actavis plc logo. (PRNewsFoto/Actavis plc)

Actavis and Forest Shareholders Approve Proposals Related to Actavis' Planned Acquisition of Forest

Actavis plc (NYSE: ACT) and Forest Laboratories, Inc. (NYSE: FRX) today announced that, at shareholder meetings held today, all proposals related...

Jun 12, 2014, 18:16 ET
Actavis plc logo. (PRNewsFoto/Actavis plc)

Actavis Announces Receipt of Requisite Consents and Expiration of Consent Solicitations for Forest Laboratories Senior Notes

Actavis plc (NYSE: ACT) today announced that Forest Laboratories, Inc. (NYSE: FRX) has received valid consents (the "Requisite Consents") from...

Jun 10, 2014, 17:19 ET
Actavis plc logo. (PRNewsFoto/Actavis plc)

Actavis Prices $3.7 Billion of Senior Unsecured Notes

Actavis plc (NYSE: ACT) today announced that its indirect subsidiary, Actavis Funding SCS, priced a private debt offering of $500 million of...

Jun 10, 2014, 08:48 ET
Actavis plc logo. (PRNewsFoto/Actavis plc)

Actavis Announces Offering of Senior Unsecured Notes

Actavis plc (NYSE: ACT) today announced that its indirect subsidiary, Actavis Funding SCS, is privately offering three, five, ten and thirty year...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge